Stuart Roberts is the bio analyst - excellent analyst but always over estimated valuations. His valuation for ADO was one of the more realistic at 13c but he hasn't updated his research in 2 years and still sends out weekly with old info on ADO and wrong prices. He hasn't updated the signed clients for eBio either.
I am pretty sure the main reason he ever covered ADO was because the Chair of the London arm of his broker was a holder and the brother of the CEO.
ADO doesn't 'fit' a brokers attention - they don't need money as they are around about self sufficient so you can't make money from a capital raising and they arn't big enough to hit the radar of the insto funds that pay a broker with transactional business.
ADO Price at posting:
6.1¢ Sentiment: Buy Disclosure: Held
